LivaNova
LIVN
185 hedge funds and large institutions have $1.97B invested in LivaNova in 2020 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 65 reducing their positions, and 52 closing their positions.
346% more call options, than puts
Call options by funds: $1.61M | Put options by funds: $362K
2% less repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 65
1.66% less ownership
Funds ownership: 91.6% → 89.94% (-1.7%)
15% less funds holding
Funds holding: 217 → 185 (-32)
41% less capital invested
Capital invested by funds: $3.34B → $1.97B (-$1.37B)
52% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 52
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
+$79.4M |
| 2 |
Primecap Management
Pasadena,
California
|
+$64.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$50.6M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$24.3M |
| 5 |
Harris Associates
Chicago,
Illinois
|
+$18.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$77M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$45.5M |
| 3 |
BM
Bridger Management
New York
|
-$38.3M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$30.1M |
| 5 |
Capital World Investors
Los Angeles,
California
|
-$24.1M |
LIVN Hedge Fund Activity: Q1 2020 in Review
185 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in LivaNova (LIVN) for Q1 2020, worth a combined $1.97B — down 41% from $3.34B a quarter earlier.
Sellers outnumbered buyers: 52 funds closed out of LIVN and 25 opened new positions — a net loss of 27 holders — while 65 trimmed existing stakes and 64 added.
The largest buyer was HealthCor Management, opening a new position worth an estimated $79.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $77M.
- 185 institutional investors held LivaNova (LIVN) as of Q1 2020, down from 217 in Q4 2019.
- Funds reported $1.97B of LivaNova stock for Q1 2020, down 41% quarter-over-quarter.
- 25 funds opened new LivaNova positions in Q1 2020 and 52 closed out, a net change of -27 holders.
- The largest LivaNova buyer in Q1 2020 was HealthCor Management, an estimated $79.4M added.
- The largest LivaNova seller in Q1 2020 was T. Rowe Price Associates, an estimated $77M sold.
Based on aggregated 13F filings for Q1 2020.